Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Oldenburg

Showing results (31-40 of 330) with videos related to

Pageof 33
Sort By:
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 23, 2002
Inhibitor development in correlation to factor VIII genotypesJ Oldenburg, O El-Maarri, R Schwaab
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 26, 2014
Genomics of bleeding disordersA C Goodeve, A Pavlova, J Oldenburg
Hamostaseologie|November 9, 2016
VKCFD2 - from clinical phenotype to molecular mechanismK J Czogalla, M Watzka, J Oldenburg
Journal of Thrombosis and Haemostasis : JTH|December 15, 2015
A critical appraisal of one-stage and chromogenic assays of factor VIII activityF Peyvandi, J Oldenburg, K D Friedman
Vox Sanguinis|January 1, 1996
Immune tolerance for the treatment of factor VIII inhibitors--twenty years' 'bonn protocol'H H Brackmann, J Oldenburg, R Schwaab
Hamostaseologie|November 8, 2011
[Comprehensive Care Center Bonn from 1980 to 2009. Changes in the epidemiology and regional composition of the haemophilia population]I Besmens, H-H Brackmann, J Oldenburg
Vox Sanguinis|October 26, 1999
Induction of immune tolerance in haemophilia A inhibitor patients by the 'Bonn Protocol': predictive parameter for therapy duration and outcomeJ Oldenburg, R Schwaab, H H Brackmann
Haematologica|February 24, 2001
Risk factors for inhibitor development in hemophilia AJ Oldenburg, H H Brackmann, R Schwaab
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 1, 2014
ITI choice for the optimal management of inhibitor patients - from a clinical and pharmacoeconomic perspectiveJ Oldenburg, S K Austin, C M Kessler
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 14, 2004
Molecular basis of haemophilia AJ Oldenburg, N M Ananyeva, E L Saenko
Pageof 33

Showing results (31-40 of 330) with videos related to

Sort By:
Pageof 33
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 23, 2002
Inhibitor development in correlation to factor VIII genotypesJ Oldenburg, O El-Maarri, R Schwaab
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 26, 2014
Genomics of bleeding disordersA C Goodeve, A Pavlova, J Oldenburg
Hamostaseologie|November 9, 2016
VKCFD2 - from clinical phenotype to molecular mechanismK J Czogalla, M Watzka, J Oldenburg
Journal of Thrombosis and Haemostasis : JTH|December 15, 2015
A critical appraisal of one-stage and chromogenic assays of factor VIII activityF Peyvandi, J Oldenburg, K D Friedman
Vox Sanguinis|January 1, 1996
Immune tolerance for the treatment of factor VIII inhibitors--twenty years' 'bonn protocol'H H Brackmann, J Oldenburg, R Schwaab
Hamostaseologie|November 8, 2011
[Comprehensive Care Center Bonn from 1980 to 2009. Changes in the epidemiology and regional composition of the haemophilia population]I Besmens, H-H Brackmann, J Oldenburg
Vox Sanguinis|October 26, 1999
Induction of immune tolerance in haemophilia A inhibitor patients by the 'Bonn Protocol': predictive parameter for therapy duration and outcomeJ Oldenburg, R Schwaab, H H Brackmann
Haematologica|February 24, 2001
Risk factors for inhibitor development in hemophilia AJ Oldenburg, H H Brackmann, R Schwaab
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 1, 2014
ITI choice for the optimal management of inhibitor patients - from a clinical and pharmacoeconomic perspectiveJ Oldenburg, S K Austin, C M Kessler
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 14, 2004
Molecular basis of haemophilia AJ Oldenburg, N M Ananyeva, E L Saenko
Pageof 33